SMAD3 and Hepatic fibrosis: Among patients with liver fibrosis and hepatocellular carcinoma infected because of hepatitis B virus (HBV) infection, miR-34a-5p inhibits liver fibrosis by regulating the TGF-β1/Smad3 pathway [33].